Advanced Search

Technical Analysis for EIGR - Eiger BioPharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade B 10.96 -3.78% -0.43
EIGR closed down 3.78 percent on Thursday, August 6, 2020, on 41 percent of normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.
3 Watchers
Watchlist Portfolio

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Up
Historical EIGR trend table...
Date Alert Name Type % Chg
Stochastic Sell Signal Bearish 0.00%
Upper Bollinger Band Walk Strength 0.00%
Earnings Movers Other 0.00%
Overbought Stochastic Strength 0.00%
NR7 Range Contraction -3.78%
Stochastic Reached Overbought Strength -3.78%
Upper Bollinger Band Walk Strength -3.78%
Above Upper BB Strength -3.78%
Overbought Stochastic Strength -3.78%
Up 3 Days in a Row Strength -3.78%
Older EOD signals for EIGR ...
View Intraday Alerts

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Track My Stocks
Configure default chart indicators Basic chart:

Profile

Eiger BioPharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops a portfolio of late-stage drugs for orphan diseases. It offers Sarasar, which is used for the treatment of hepatitis delta; Exendin that is used for the treatment of hypoglycemia; and Bestatin, which is used for the treatment of pulmonary arterial hypertension and lymphedema. Eiger BioPharmaceuticals, Inc. was founded in 2008 and is based in Palo Alto, California.
Biotechnology Biopharmaceutical Life Sciences Pharmaceutical Industry Pharmacy Specialty Drugs Pulmonary Arterial Hypertension Hepatitis Pulmonary Hypertension Orphan Diseases Hypoglycemia

Is EIGR a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

Recent News

Date Title
Aug 6 Eiger BioPharmaceuticals Reports Second Quarter 2020 Financial Results and Provides Business Update
Aug 3 Eiger BioPharmaceuticals to Participate in Upcoming August 2020 Investor Conferences
Jul 17 Is Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR) Popular Amongst Institutions?
Jul 13 Did Hedge Funds Make The Right Call On Eiger BioPharmaceuticals, Inc. (EIGR) ?
Jul 8 Eiger BioPharma (EIGR) Upgraded to Strong Buy: What Does It Mean for the Stock?
Jun 24 Why Eiger BioPharmaceuticals (EIGR) Stock Might be a Great Pick
Jun 8 Hedge Funds Can’t Buy Enough Of Eiger BioPharmaceuticals, Inc. (EIGR)
May 29 Eiger BioPharmaceuticals, Inc. to Hold Virtual Annual Meeting of Stockholders on June 15, 2020
May 26 Eiger to Present at Jefferies Virtual Healthcare Conference 2020
May 20 Eiger NDA Accepted, And Other News: The Good, Bad And Ugly Of Biopharma
See more EIGR news...

Indicators

Indicator Value
52 Week High 15.82
52 Week Low 4.55
Average Volume 373,870
200-Day Moving Average 10.71
50-Day Moving Average 10.40
20-Day Moving Average 10.17
10-Day Moving Average 10.52
Average True Range 0.67
ADX 20.27
+DI 24.02
-DI 12.91
Chandelier Exit (Long, 3 ATRs ) 9.65
Chandelier Exit (Short, 3 ATRs ) 10.98
Upper Bollinger Band 11.46
Lower Bollinger Band 8.89
Percent B (%b) 0.81
BandWidth 25.25
MACD Line 0.24
MACD Signal Line 0.08
MACD Histogram 0.1646
Fundamentals Value
Market Cap 91.7 Million
Num Shares 8.37 Million
EPS -5.68
Price-to-Earnings (P/E) Ratio -1.93
Price-to-Sales 0.00
Price-to-Book 4.37
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 11.82
Resistance 3 (R3) 11.87 11.65 11.67
Resistance 2 (R2) 11.65 11.43 11.62 11.62
Resistance 1 (R1) 11.30 11.29 11.19 11.25 11.58
Pivot Point 11.08 11.08 11.02 11.05 11.08
Support 1 (S1) 10.73 10.86 10.62 10.68 10.34
Support 2 (S2) 10.51 10.72 10.48 10.30
Support 3 (S3) 10.16 10.51 10.25
Support 4 (S4) 10.11